AMA
Spahiu L, Behluli E, Peterlin B, et al. Mucopolysaccharidosis III: Molecular basis and treatment. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(3):199-208. doi:10.5114/pedm.2021.109270.
APA
Spahiu, L., Behluli, E., Peterlin, B., Nefic, H., Hadziselimovic, R., & Liehr, T. et al. (2021). Mucopolysaccharidosis III: Molecular basis and treatment. Pediatric Endocrinology Diabetes and Metabolism, 27(3), 199-208. https://doi.org/10.5114/pedm.2021.109270
Chicago
Spahiu, Lidvana, Emir Behluli, Borut Peterlin, Hilada Nefic, Rifat Hadziselimovic, Thomas Liehr, and Gazmend Temaj. 2021. "Mucopolysaccharidosis III: Molecular basis and treatment". Pediatric Endocrinology Diabetes and Metabolism 27 (3): 199-208. doi:10.5114/pedm.2021.109270.
Harvard
Spahiu, L., Behluli, E., Peterlin, B., Nefic, H., Hadziselimovic, R., Liehr, T., and Temaj, G. (2021). Mucopolysaccharidosis III: Molecular basis and treatment. Pediatric Endocrinology Diabetes and Metabolism, 27(3), pp.199-208. https://doi.org/10.5114/pedm.2021.109270
MLA
Spahiu, Lidvana et al. "Mucopolysaccharidosis III: Molecular basis and treatment." Pediatric Endocrinology Diabetes and Metabolism, vol. 27, no. 3, 2021, pp. 199-208. doi:10.5114/pedm.2021.109270.
Vancouver
Spahiu L, Behluli E, Peterlin B, Nefic H, Hadziselimovic R, Liehr T et al. Mucopolysaccharidosis III: Molecular basis and treatment. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(3):199-208. doi:10.5114/pedm.2021.109270.